Heling Zhou

792 total citations
36 papers, 636 citations indexed

About

Heling Zhou is a scholar working on Radiology, Nuclear Medicine and Imaging, Biomedical Engineering and Cancer Research. According to data from OpenAlex, Heling Zhou has authored 36 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Biomedical Engineering and 12 papers in Cancer Research. Recurrent topics in Heling Zhou's work include Advanced MRI Techniques and Applications (13 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Nanoplatforms for cancer theranostics (11 papers). Heling Zhou is often cited by papers focused on Advanced MRI Techniques and Applications (13 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Nanoplatforms for cancer theranostics (11 papers). Heling Zhou collaborates with scholars based in United States, China and Japan. Heling Zhou's co-authors include Dawen Zhao, Ralph P. Mason, Rami R. Hallac, Philip E. Thorpe, Strahinja Stojadinović, Peter Peschke, Olivier Belzile, Liang Zhang, Timothy D. Solberg and Rajesh Pidikiti and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Heling Zhou

35 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heling Zhou United States 16 241 210 162 148 102 36 636
Tord Hompland Norway 17 360 1.5× 241 1.1× 211 1.3× 175 1.2× 111 1.1× 35 857
Marie-Hélène Gagnon United States 13 245 1.0× 132 0.6× 140 0.9× 289 2.0× 65 0.6× 29 877
Xiaoxia Xu China 18 249 1.0× 138 0.7× 155 1.0× 174 1.2× 142 1.4× 54 731
Samata Kakkad United States 18 162 0.7× 141 0.7× 251 1.5× 290 2.0× 129 1.3× 30 756
Yesen Li China 15 230 1.0× 215 1.0× 85 0.5× 307 2.1× 111 1.1× 45 766
Jiangtao Sun China 12 111 0.5× 113 0.5× 115 0.7× 227 1.5× 72 0.7× 21 547
Lionel Mignion Belgium 14 168 0.7× 102 0.5× 273 1.7× 286 1.9× 73 0.7× 34 706
Jingdan Qiu China 6 105 0.4× 316 1.5× 104 0.6× 150 1.0× 137 1.3× 9 722
Sarah Tucker Marrison United States 6 77 0.3× 145 0.7× 172 1.1× 276 1.9× 106 1.0× 10 603
Deqiang Kou China 5 94 0.4× 246 1.2× 95 0.6× 99 0.7× 123 1.2× 11 507

Countries citing papers authored by Heling Zhou

Since Specialization
Citations

This map shows the geographic impact of Heling Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heling Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heling Zhou more than expected).

Fields of papers citing papers by Heling Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heling Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heling Zhou. The network helps show where Heling Zhou may publish in the future.

Co-authorship network of co-authors of Heling Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Heling Zhou. A scholar is included among the top collaborators of Heling Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heling Zhou. Heling Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhou, Heling, et al.. (2021). CircHIPK3 modulates VEGF through MiR-7 to affect ovarian cancer cell proliferation and apoptosis.. PubMed. 26(3). 691–697. 8 indexed citations
3.
Zhou, Heling, et al.. (2020). In vivo hypoxia characterization using blood oxygen level dependent magnetic resonance imaging in a preclinical glioblastoma mouse model. Magnetic Resonance Imaging. 76. 52–60. 15 indexed citations
4.
5.
Lickliter, Jason D., Jeremy Ruben, Ross Jennens, et al.. (2019). ACTR-18. A PHASE IB/II CLINICAL TRIAL OF DODECAFLUOROPENTANE EMULSION (DDFPE) AS A RADIOSENSITIZER IN GLIOBLASTOMA. Neuro-Oncology. 21(Supplement_6). vi16–vi16. 2 indexed citations
6.
Yang, Donghan M., et al.. (2019). Oxygen‐sensitive MRI assessment of tumor response to hypoxic gas breathing challenge. NMR in Biomedicine. 32(7). e4101–e4101. 19 indexed citations
7.
Zhou, Heling, et al.. (2018). Oxygenation Imaging by Nuclear Magnetic Resonance Methods. Methods in molecular biology. 1718. 297–313. 5 indexed citations
8.
Zhou, Heling, et al.. (2018). Tomographic breathing detection: a method to noninvasively assess in situ respiratory dynamics. Journal of Biomedical Optics. 23(5). 1–1. 5 indexed citations
9.
Chen, Zhi, Vani P. Mocharla, Tracy E. Strecker, et al.. (2018). Synthesis of dihydronaphthalene analogues inspired by combretastatin A-4 and their biological evaluation as anticancer agents. MedChemComm. 9(10). 1649–1662. 20 indexed citations
10.
Dey, Sanchareeka, Sharda Kumari, Sarada Preeta Kalainayakan, et al.. (2017). The vascular disrupting agent combretastatin A-4 phosphate causes prolonged elevation of proteins involved in heme flux and function in resistant tumor cells. Oncotarget. 9(3). 4090–4101. 26 indexed citations
11.
Zhang, Zhang, Olivier Belzile, Heling Zhou, et al.. (2016). Effective Rat Lung Tumor Model for Stereotactic Body Radiation Therapy. Radiation Research. 185(6). 616–622. 8 indexed citations
12.
Hallac, Rami R., Heling Zhou, Rajesh Pidikiti, et al.. (2016). A role for dynamic contrast-enhanced magnetic resonance imaging in predicting tumour radiation response. British Journal of Cancer. 114(11). 1206–1211. 10 indexed citations
13.
Lickliter, Jason D., Jeremy Ruben, David B. Wilson, et al.. (2016). Abstract 4247: TOLD MRI validation of reversal of tumor hypoxia in glioblastoma with a novel oxygen therapeutic. Cancer Research. 76(14_Supplement). 4247–4247. 2 indexed citations
14.
Zhou, Heling, James W. Campbell, Ramona Lopez, et al.. (2016). Monitoring Tumor Response to Vascular Disrupting Agent Using Photoacoustic Tomography and Multiparametric MRI. 57. 1408–1408. 3 indexed citations
15.
Zhou, Heling & Dawen Zhao. (2014). Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI. Journal of Visualized Experiments. 16 indexed citations
16.
Zhang, Liang, Heling Zhou, Olivier Belzile, Philip E. Thorpe, & Dawen Zhao. (2014). Phosphatidylserine-targeted bimodal liposomal nanoparticles for in vivo imaging of breast cancer in mice. Journal of Controlled Release. 183. 114–123. 60 indexed citations
17.
Zhou, Heling, Min Chen, & Dawen Zhao. (2013). Longitudinal MRI Evaluation of Intracranial Development and Vascular Characteristics of Breast Cancer Brain Metastases in a Mouse Model. PLoS ONE. 8(4). e62238–e62238. 14 indexed citations
18.
Saha, Debabrata, Heling Zhou, Hiroshi Harada, et al.. (2011). <em>In vivo</em> Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model. Journal of Visualized Experiments. 14 indexed citations
19.
Zhao, Dawen, Jason H. Stafford, Heling Zhou, & Philip E. Thorpe. (2011). Near-infrared Optical Imaging of Exposed Phosphatidylserine in a Mouse Glioma Model. Translational Oncology. 4(6). 355–364. 32 indexed citations
20.
Zhou, Heling, Katherine Luby‐Phelps, Bruce Mickey, et al.. (2009). Dynamic Near-Infrared Optical Imaging of 2-Deoxyglucose Uptake by Intracranial Glioma of Athymic Mice. PLoS ONE. 4(11). e8051–e8051. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tord Hompland Breakdown of academic impact, for papers by Marie-Hélène Gagnon Breakdown of academic impact, for papers by Xiaoxia Xu Breakdown of academic impact, for papers by Samata Kakkad Breakdown of academic impact, for papers by Yesen Li Breakdown of academic impact, for papers by Jiangtao Sun Breakdown of academic impact, for papers by Lionel Mignion Breakdown of academic impact, for papers by Jingdan Qiu Breakdown of academic impact, for papers by Sarah Tucker Marrison Breakdown of academic impact, for papers by Deqiang Kou
Rankless by CCL
2026